Related references
Note: Only part of the references are listed.A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells
Srikumar M. Raja et al.
CANCER BIOLOGY & THERAPY (2010)
Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities
Macus Tien Kuo
ANTIOXIDANTS & REDOX SIGNALING (2009)
SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK
Yutaka Okawa et al.
BLOOD (2009)
Tumor Protein 53-Induced Nucear Protein 1 Is a Major Mediator of p53 Antioxidant Function
Carla E. Cano et al.
CANCER RESEARCH (2009)
Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90
Byoung Heon Kang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
hSirT1-Dependent Regulation of the PCAF-E2F1-p73 Apoptotic Pathway in Response to DNA Damage
Natalia Pediconi et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Mitofusin 2: A mitochondria-shaping protein with signaling roles beyond fusion
Olga Martins De Brito et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
The dual functions of thiol-based peroxidases in H2O2 scavenging and signaling
Simon Fourquet et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
Rui Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2
B. H. Y. Yeung et al.
BRITISH JOURNAL OF CANCER (2008)
Mitochondria-targeted antioxidant enzyme activity regulates radioresistance in human pancreatic cancer cells
Carolyn J. Fisher et al.
CANCER BIOLOGY & THERAPY (2008)
NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance
Danyelle M. Townsend et al.
CANCER RESEARCH (2008)
Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth
Tsutonm Ohta et al.
CANCER RESEARCH (2008)
Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel
Ayana Sawai et al.
CANCER RESEARCH (2008)
Apoptosis and non-apoptotic deaths in cancer development and treatment response
Elza C. de Bruin et al.
CANCER TREATMENT REVIEWS (2008)
Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer
Irma Meijerman et al.
CANCER TREATMENT REVIEWS (2008)
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Xiao-Jun Wang et al.
CARCINOGENESIS (2008)
Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival
E. Giannoni et al.
CELL DEATH AND DIFFERENTIATION (2008)
Selenium compounds and selenoproteins in cancer
Regina Brigelius-Flohe
CHEMISTRY & BIODIVERSITY (2008)
SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers
Sarat Chandarlapaty et al.
CLINICAL CANCER RESEARCH (2008)
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies
Suresh S. Ramalingam et al.
CLINICAL CANCER RESEARCH (2008)
Her2-positive breast cancer: Herceptin and beyond
Windy Dean-Colomb et al.
EUROPEAN JOURNAL OF CANCER (2008)
Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2
Jingbo Pi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Resistance mechanisms to cancer chemotherapy
Kelly Marie Redmond et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Dual roles of Nrf2 in cancer
Alexandria Lau et al.
PHARMACOLOGICAL RESEARCH (2008)
Heme oxygenase-1 in tumors: Is it a false friend?
Alicja Jozkowicz et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis
N. Montesano Gesualdi et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2007)
Regulation of tumor cell mitochondrial Homeostasis by an organelle-specific Hsp90 chaperone network
Byoung Heon Kang et al.
CELL (2007)
Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome
Ahsan M. Kaimul et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Thioredoxin signaling as a target for cancer therapy
Garth Powis et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Are peroxiredoxins tumor suppressors?
Carola Anke Neumann et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress
Molly M. Gallogly et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Jun Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cellular response to infrared radiation involves retrograde mitochondrial signaling
Peter Schroeder et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Mitochondria as key components of the stress response
Irini Manoli et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer
Joo-Heon Kim et al.
CLINICAL CANCER RESEARCH (2007)
The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis
Andrea Rasola et al.
APOPTOSIS (2007)
Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease
Salvador Mena et al.
CLINICAL CANCER RESEARCH (2007)
A phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors
Ramesh K. Ramanathan et al.
CLINICAL CANCER RESEARCH (2007)
Heat shock genes - integrating cell survival and death
Richa Arya et al.
JOURNAL OF BIOSCIENCES (2007)
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
David B. Solit et al.
CLINICAL CANCER RESEARCH (2007)
Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies
Peeter Karihtala et al.
APMIS (2007)
Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation:: Implication to tumor biology
Yun-Jeong Kim et al.
CANCER RESEARCH (2007)
Oxidative modification of proteins: Age-related changes
Bulbul Chakravarti et al.
GERONTOLOGY (2007)
Protein tyrosine phosphorylation and reversible oxidation: Two cross-talking posttranslation modifications
Paola Chiarugi et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy
J. Daniel Pennington et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Mitochondrial c-Jun NH2-terminal kinase prevents the accumulation of reactive oxygen species and reduces necrotic damage in neural tumor cells that lack trophic support
Noelia Lopez-Sanchez et al.
MOLECULAR CANCER RESEARCH (2007)
p53 suppresses the Nrf2-dependent transcription of antioxidant response genes
Raffaella Faraonio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Chemotherapy: induction of stress responses
E. Tiligada
ENDOCRINE-RELATED CANCER (2006)
The thioredoxin system in cancer
Elias S. J. Arner et al.
SEMINARS IN CANCER BIOLOGY (2006)
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer
Anju Singh et al.
PLOS MEDICINE (2006)
Antileukemic activity of shepherdin and molecular diversity of Hsp90 inhibitors
Boglarka Gyurkocza et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Thioredoxin reductase as a novel molecular target for cancer therapy
Phuongmai Nguyen et al.
CANCER LETTERS (2006)
AROS-29 is involved in adaptive response to oxidative stress
NM Gesualdi et al.
FREE RADICAL RESEARCH (2006)
Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase
SI Hashemy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inhibition of mammalian thioredoxin reductase by some flavonoids: Implications for myricetin and quercetin anticancer activity
J Lu et al.
CANCER RESEARCH (2006)
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
B Padmanabhan et al.
MOLECULAR CELL (2006)
Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis
S Sanderson et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment
Salvador Rodriguez-Nieto et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Thioredoxin-1 and posttranslational modifications
Judith Haendeler
ANTIOXIDANTS & REDOX SIGNALING (2006)
The role of peroxiredoxin II in radation-resistant MCF-7 breast cancer cells
TL Wang et al.
CANCER RESEARCH (2005)
Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways
HM Beere
JOURNAL OF CLINICAL INVESTIGATION (2005)
Redox-sensitive signaling factors as a novel molecular targets for cancer therapy
JD Pennington et al.
DRUG RESISTANCE UPDATES (2005)
Resistance to epidermal growth factor receptor-targeted therapy
F Morgillo et al.
DRUG RESISTANCE UPDATES (2005)
Thioredoxin reductase is irreversibly modified by curcumin - A novel molecular mechanism for its anticancer activity
JG Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
Rational design of shepherdin, a novel anticancer agent
J Plescia et al.
CANCER CELL (2005)
Protective role of MnSOD and redox regulation of neuronal cell survival
T Galeotti et al.
BIOMEDICINE & PHARMACOTHERAPY (2005)
Critical evaluation of current treatments in metastatic colorectal cancer
A Venook
ONCOLOGIST (2005)
Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins
SG Rhee et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release
M Enoksson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Multidrug Resistance-Associated Protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine Sulfoximine
Ilhan Akan et al.
CANCER CELL INTERNATIONAL (2005)
Prediction of docetaxel response in human breast cancer by gene expression profiling
K Iwao-Koizumi et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Heat shock protein 70 antisense oligonucleotide inhibits cell growth and induces apoptosis in human gastric cancer cell line SGC-7901
Zhi-Gang Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents
Y Miyata
CURRENT PHARMACEUTICAL DESIGN (2005)
ROS stress in cancer cells and therapeutic implications
H Pelicano et al.
DRUG RESISTANCE UPDATES (2004)
Redox control of signal transduction, gene expression and cellular senescence
F Esposito et al.
NEUROCHEMICAL RESEARCH (2004)
Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress
DDK Smart et al.
CANCER RESEARCH (2004)
Peroxiredoxins, a novel protein family in lung cancer
ST Lehtonen et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide
CH Lillig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mitochondrial glutathione: A modulator of brain cell death
NR Sims et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2004)
DNA damage responses to oxidative stress
A Barzilai et al.
DNA REPAIR (2004)
Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry
JJ Shen et al.
CANCER RESEARCH (2004)
Heat shock protein 70 promotes cancer cell viability by safeguarding lysosomal integrity
M Gyrd-Hansen et al.
CELL CYCLE (2004)
A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells
C Friesen et al.
CELL DEATH AND DIFFERENTIATION (2004)
Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins - Implications for mitochondrial redox regulation and antioxidant defense
SM Beer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis
H Ikeda et al.
BIOCHEMICAL JOURNAL (2004)
Hsp90: the vulnerable chaperone
G Chiosis et al.
DRUG DISCOVERY TODAY (2004)
Strategies for reversing drug resistance
T Fojo et al.
ONCOGENE (2003)
Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor
S Gurbuxani et al.
ONCOGENE (2003)
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival
J Raffel et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2003)
Protein kinase B activation by reactive oxygen species is independent of tyrosine kinase receptor phosphorylation and requires Src activity
F Esposito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses
Y Miyamoto et al.
BIOLOGICAL CHEMISTRY (2003)
Specific stimulation of human apurinic/apyrimidinic endonuclease by heat shock protein 70
F Mendez et al.
DNA REPAIR (2003)
NF-κB and IκBα are found in the mitochondria -: Evidence for regulation of mitochondrial gene expression by NF-κB
PC Cogswell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future
Udai Banerji et al.
CURRENT CANCER DRUG TARGETS (2003)
Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation
S Karimpour et al.
ONCOGENE (2002)
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
LM Butler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
JS Isaacs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Disassembly of transcriptional regulatory complexes by molecular chaperones
BC Freeman et al.
SCIENCE (2002)
Effects of a new anti-rheumatic drug KE-298 and its active metabolite: KE-758 on secretion of thioredoxin and on the level of intracellular glutathione in human monocytes and T cells
M Sugimoto et al.
MOLECULAR IMMUNOLOGY (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione
A Colell et al.
HEPATOLOGY (2001)
Hammerhead ribozyme against γ-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins
T Iida et al.
CANCER GENE THERAPY (2001)
Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression
J Nagata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Hsp90: a specialized but essential protein-folding tool
JC Young et al.
JOURNAL OF CELL BIOLOGY (2001)
The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications
F Ria et al.
BRITISH JOURNAL OF CANCER (2001)
Mitochondrial alterations, cellular response to oxidative stress and defective degradation of proteins in aging
HC Lee et al.
BIOGERONTOLOGY (2001)
Metabolism and functions of glutathione in brain
R Dringen
PROGRESS IN NEUROBIOLOGY (2000)
Oxidants, oxidative stress and the biology of ageing
T Finkel et al.
NATURE (2000)
AhpF and other NADH:peroxiredoxin oxidoreductases, homologues of low Mr thioredoxin reductase
LB Poole et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Thioredoxin reductase as a pathophysiological factor and drug target
K Becker et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes
K Hirota et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-κB, AP-1, and CREB activation in HEK293 cells
K Hirota et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Estimation of H2O2 gradients across biomembranes
F Antunes et al.
FEBS LETTERS (2000)
Thioredoxin reductase
D Mustacich et al.
BIOCHEMICAL JOURNAL (2000)
Oxidative stress and nuclear factor-kappa B activation - A reassessment of the evidence in the light of recent discoveries
A Bowie et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
